We are live on ! Find out more
QNRX

Quoin Pharmaceuticals
QNRX

5 hedge funds and large institutions have $419K invested in Quoin Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

67% more funds holding

Funds holding: 3 → 5 (+2)

9% more capital invested

Capital invested by funds: $383K → $419K (+$36K)

0.8% less ownership

Funds ownership: 2.52% → 1.72% (-0.8%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
+2
Holders Change %
+66.67%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$59.8K
2
Ameriprise
Ameriprise
Minnesota
+$29.9K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$22.4K
4
HF
HRT Financial
New York
+$22.4K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$198K
2
Renaissance Technologies
Renaissance Technologies
New York
-$44.8K
3
TSS
Two Sigma Securities
New York
-$29K
4
Bank of America
Bank of America
North Carolina
-$4K

QNRX Hedge Fund Activity: Q1 2022 in Review

5 of the 6,361 institutional investors tracked by Wall St. Rank reported a position in Quoin Pharmaceuticals (QNRX) for Q1 2022, worth a combined $419K — up 9.4% from $383K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new QNRX positions and 2 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $59.8K. The largest seller was Morgan Stanley, exiting entirely with an estimated $198K sold.

  • 5 institutional investors held Quoin Pharmaceuticals (QNRX) as of Q1 2022, up from 3 in Q4 2021.
  • Funds reported $419K of Quoin Pharmaceuticals stock for Q1 2022, up 9.4% quarter-over-quarter.
  • 4 funds opened new Quoin Pharmaceuticals positions in Q1 2022 and 2 closed out, a net change of +2 holders.
  • The largest Quoin Pharmaceuticals buyer in Q1 2022 was Virtu Financial, an estimated $59.8K added.
  • The largest Quoin Pharmaceuticals seller in Q1 2022 was Morgan Stanley, an estimated $198K sold.

Based on aggregated 13F filings for Q1 2022.